Literature DB >> 1284449

Laryngeal hyperplastic lesions, follow-up study and application of lectins and anticytokeratins for their evaluation.

V Kambic1, N Gale, D Ferluga.   

Abstract

A retrospective study of 878 biopsy specimens from 692 patients with laryngeal hyperplastic aberrations was performed according to the Kambic-Lenart classification. Special attention was focused on 88 patients with persistent or recurring disease. In these carcinoma developed in 17 (2.4%) patients, 12 (1.7%) of whom had had atypical hyperplasia. We therefore propose that the term precancerosis, which so definitely implies cancer, should be replaced with the expression risky epithelium where nothing is determined in advance, but a careful follow-up of the patients is imperative. In particular cases of laryngeal hyperplastic lesions, mainly in abnormal and in atypical hyperplasias when the tissue specimens are cut tangentially, the exact identification and position of individual epithelial cells is essential. In such cases histochemical and immunohistochemical methods yield more precise evaluation. Lectins and cytokeratins provide good markers of epithelial maturation. These results contribute to a more useful evaluation of laryngeal hyperplastic lesions, crucial for the choice of adequate therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284449     DOI: 10.1016/S0344-0338(11)81253-7

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

Review 1.  Oral premalignant lesions: from the pathological viewpoint.

Authors:  Toshiyuki Izumo
Journal:  Int J Clin Oncol       Date:  2011-01-14       Impact factor: 3.402

2.  [Current classification of precursor lesions of oral squamous cell carcinoma principles of the WHO classification 2005].

Authors:  O Driemel; K Hertel; T E Reichert; H Kosmehl
Journal:  Mund Kiefer Gesichtschir       Date:  2006-03

3.  Laryngeal papillomatosis: molecular, histopathological, and clinical evaluation.

Authors:  N Gale; M Poljak; V Kambic; D Ferluga; J Fischinger
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.